130 likes | 146 Views
Read here the market research report.
E N D
Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker
CARDIAC IMPLANTABLE ELECTRONIC DEVICE MARKET ANALYSIS Cardiac Implantable Electronic Device Market, By Type (Implantable Pacemakers and External Pacemakers), By End User (Hospitals, Specialty Clinics, and Ambulatory Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Impact of Coronavirus (Covid-19) Pandemic • During this COVID-19 pandemic situation, the global cardiac implantable electronic device market has caused an influx of patients in hospitals and acute care facilities. As a result, any procedure or service is being shut down immediately. Many hospitals have already categorized cardiac implantable device as ‘non-essential’. Patients with cardiovascular disease are at high risk of being affected by COVID-19 infection, which can lead to death. • The global cardiac implantable electronic device market is estimated to be valued at US$ 22,576.22 million in 2020 and is expected to exhibit a CAGR of 7.7% during the forecast period (2020-2027).
Figure 1: Global Cardiac Implantable Electronic Device Market Share(%) Analysis, By Type, 2020
Global Cardiac Implantable Electronic Device Market - Restraints • However, implantable pacemaker associated infections in cardiac patients can deter patients from using this product, which is expected to negatively impact growth of the market.
Cardiac Implantable Electronic Device Market – Regional Analysis • North America accounted for the largest share in the global cardiac implantable electronic device market in 2019, owing to increasing prevalence of cardiovascular diseases in the region. According to the American Heart Association (AHA), 2017, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. • Furthermore, Asia Pacific is also expected to witness significant growth in the global cardiac implantable electronic device market, owing to high demand for technologically advanced products for cardiac rhythm management and rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of which 2.9 million may suffer from AF-associated strokes.
Figure 2: Global Cardiac Implantable Electronic Device Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Competitive Landscape • Key players operating in the global cardiac implantable electronic device market include Medtronic plc., Biotronik, Boston Scientific Corporation, Shree Pacetronix Ltd., CCC Medical Devices, Cook Group Incorporated, BraileBiomédica, Abbott Laboratories, Sorin Group, Osypka Medical GmbH, Galix Biomedical Instrumentation Inc., and Oscor Inc..
Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst • Buy Now Reference:https://www.coherentmarketinsights.com/market-insight/cardiac-implantable-electronic-device-market-3949
About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis
Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com
Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/